A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes. (Q51381372)
Jump to navigation
Jump to search
scientific article published on 19 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes. |
scientific article published on 19 January 2011 |
Statements
1 reference
A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes. (English)
1 reference
P Barrington
1 reference
J Y Chien
1 reference
H D H Showalter
1 reference
K Schneck
1 reference
S Cui
1 reference
F Tibaldi
1 reference
B Ellis
1 reference
T A Hardy
1 reference
19 January 2011
1 reference
13
1 reference
426-433
1 reference
5
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference